科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一,在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业,通过齐心协力确保高品质治疗与成功康复。

行此手术的医生

编辑搜索过滤条件
close

缩小搜索范围

  1. 查找姓氏以该字母开头的医生 A
  2. 查找姓氏以该字母开头的医生 B
  3. 查找姓氏以该字母开头的医生 C
  4. 未找到姓氏以该字母开头的医生 D
  5. 未找到姓氏以该字母开头的医生 E
  6. 查找姓氏以该字母开头的医生 F
  7. 查找姓氏以该字母开头的医生 G
  8. 查找姓氏以该字母开头的医生 H
  9. 查找姓氏以该字母开头的医生 I
  10. 未找到姓氏以该字母开头的医生 J
  11. 查找姓氏以该字母开头的医生 K
  12. 查找姓氏以该字母开头的医生 L
  13. 未找到姓氏以该字母开头的医生 M
  14. 未找到姓氏以该字母开头的医生 N
  15. 未找到姓氏以该字母开头的医生 O
  16. 查找姓氏以该字母开头的医生 P
  17. 未找到姓氏以该字母开头的医生 Q
  18. 未找到姓氏以该字母开头的医生 R
  19. 主动 查找姓氏以该字母开头的医生 S
  20. 查找姓氏以该字母开头的医生 T
  21. 未找到姓氏以该字母开头的医生 U
  22. 未找到姓氏以该字母开头的医生 V
  23. 未找到姓氏以该字母开头的医生 W
  24. 未找到姓氏以该字母开头的医生 X
  25. 未找到姓氏以该字母开头的医生 Y
  26. 未找到姓氏以该字母开头的医生 Z
重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

姓氏首字母: S

  1. Paras H. Shah, M.D.

    Paras H. Shah, M.D.

    1. Oncologist
    2. Urologist
    1. Rochester, MN
    擅长领域:

    Bladder removal, Robotic surgery, Prostatectomy, Nephrectomy, Robotic prostatectomy, Urinary diversion, Laparoscopic su...rgery, Partial nephrectomy, Laparoscopic kidney surgery, Kidney cancer, Prostate cancer, Bladder cancer, Benign prostatic hyperplasia, Ureteral cancer

研究

妙佑医疗国际泌尿外科研究部的医生和科学家正在研究治疗前列腺癌和其他泌尿系统状况的新方案。研究人员积极参与研究根治性前列腺切除术后的长期预后。研究成果改善了治疗效果和临床实践,让患者在新疗法广泛应用之前通过参加试验获得接受新疗法的机会。

几十年来,妙佑医疗国际一直在维护前列腺癌手术患者的数据库记录。妙佑医疗的研究人员利用这些信息来监测治疗效果,发现趋势并确保整体高质量护理。

前列腺癌研究是在与妙佑医疗国际综合癌症中心的协作下进行的。美国国家癌症研究所为妙佑医疗国际综合癌症中心提供资助并将其指定为综合癌症中心,这是对其在癌症预防、诊断和治疗方面的卓越科学成就和多学科资源的认可。

妙佑医疗国际的泌尿外科致力于持续开展研究,以推动开发针对前列腺癌和其他泌尿系统状况的治疗方案。最新研究包括评估泌尿外科团队在疗效方面的一致性,以及评估磁技术在优化机器人前列腺切除术中的应用。其他研究对机器人前列腺切除术后的生活质量和手术预后进行随访。这类研究可确保妙佑医疗国际的外科医生为接受这类手术的患者提供最高水平的护理。

著述

请参阅美国国家医学图书馆检索服务系统 PubMed 所收录的妙佑医疗国际医生在机器人前列腺切除术领域的著述目录

Research Profiles

Jan. 13, 2026
  1. Khanna A (voice recording). Mayo Clinic; recorded Oct. 2024.
  2. McVary KT. Surgical treatment of benign prostatic hyperplasia (BPH). https://www.uptodate.com/contents/search. Accessed July 28, 2025.
  3. Health Education & Content Services. Your robotic-assisted prostate surgery. Mayo Clinic; 2024.
  4. Surgery for prostate cancer. Prostate Cancer Foundation. https://www.pcf.org/about-prostate-cancer/prostate-cancer-treatment/surgery-prostate-cancer/. Accessed July 28, 2025.
  5. Dmochowski RR, et al., eds. Simple prostatectomy — Open, laparoscopic, and robotic approaches. In: Campbell-Walsh-Wein Urology. 13th ed. Elsevier; 2026. https://www.clinicalkey.com. Accessed July 28, 2025.
  6. Surgery for prostate cancer. American Cancer Society. https://www.cancer.org/cancer/types/prostate-cancer/treating/surgery.html. Accessed July 28, 2025.
  7. Moreira DM, et al. Evaluation of pT0 prostate cancer in patients undergoing radical prostatectomy. BJU International. 2017; doi:10.1111/bju.13266.
  8. Motterle G, et al. The role of radical prostatectomy and lymph node dissection in clinically node positive patients. Frontiers in Oncology. 2019; doi:10.3389/fonc.2019.01395.
  9. Ami TR. Allscripts EPSi. Mayo Clinic. March 29, 2024.
  10. Costello AJ. Considering the role of radical prostatectomy in 21st century prostate cancer care. Nature Reviews Urology. 2020; doi:10.1038/s41585-020-0287-y.
  11. Agarwal DK, et al. Initial experience with da Vinci single-port robot-assisted radical prostatectomies. European Urology. 2020; doi:10.1016/j.eururo.2019.04.001.
  12. Ashfaq A, et al. Incidence and outcomes of ventral hernia repair after robotic retropubic prostatectomy: A retrospective cohort of 570 consecutive cases. International Journal of Surgery. 2017; doi:10.1016/j.ijsu.2016.12.034.
  13. Moris L, et al. Impact of lymph node burden on survival of high-risk prostate cancer patients following radical prostatectomy and pelvic lymph node dissection. Frontiers in Surgery. 2016; doi:10.3389/fsurg.2016.00065.
  14. Kaushik D, et al. Oncological outcomes following radical prostatectomy for patients with pT4 prostate cancer. International Brazilian Journal of Urology. 2016; doi:10.1590/S1677-5538.IBJU.2016.0290.
  15. Alshalalfa M, et al. Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: Exploratory analysis from 12,076 patients. Oncotarget. 2017; doi:10.18632/oncotarget.15133.
  16. Preparing for surgery: Checklist. American Society of Anesthesiologists. https://www.asahq.org/madeforthismoment/preparing-for-surgery/prep/preparing-for-surgery-checklist/. Accessed July 28, 2025.
  17. Dess RT, et al. Association of presalvage radiotherapy PSA levels after prostatectomy with outcomes of long-term antiandrogen therapy in men with prostate cancer. JAMA Oncology. 2020; doi:10.1001/jamaoncol.2020.0109.
  18. Richie JP. Radical prostatectomy for localized prostate cancer. https://www.uptodate.com/contents/search. Accessed July 28, 2025.
  19. He S, et al. Robot-assisted radical resection in prostate cancer comparative assessment with conventional laparoscopic prostatectomy: A retrospective comparative cohort study with single-center experience. Translational Andrology and Urology. 2022: doi: 10.21037/tau-22-739.
  20. Stringfield SB, et al. Experience with 10 years of a robotic surgery program at an academic medical center. Surgical Endoscopy. 2021; doi:10.1007/s00464-021-08478-y.
  21. Salinas CS, et al. Efficacy of robotic-assisted prostatectomy in localized prostate cancer: A systematic review of clinical trials. Advances in Urology. 2013; doi:10.1155/2013/105651.
  22. Kim DK, et al. Comparison of robot-assisted, laparoscopic, and open radical prostatectomy outcomes: A systematic review and network meta-analysis from KSER update series. Medicina. 2025; doi:10.3390/medicina61010061.
  23. Franco A, et al. Single port robot-assisted radical and simple prostatectomy: A systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 2024; doi:10.1038/s41391-024-00787-2.
  24. Transurethral resection of the prostate (TURP). Mayo Clinic. https://www.mayoclinic.org/tests-procedures/turp/about/pac-20384880. Accessed Aug. 1, 2025.
  25. Prostate cancer. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/prostate-cancer/symptoms-causes/syc-20353087. Accessed Aug. 1, 2025.
  26. Azad AA, et al. Enzalutamide and prostate-specific antigen levels in metastatic prostate cancer: A secondary analysis of the ARCHES randomized clinical trial. JAMA Network Open. 2025; doi:10.1001/jamanetworkopen.2025.8751.
  27. Primary care management of the post prostate cancer patient. Video. Mayo Clinic; 2021. https://educationmedia.mayo.edu/media/Primary%20Care%20Management%20of%20the%20Post%20Prostate%20Cancer%20Patient/1_sqwb1249. Accessed Sept. 8, 2025.
  28. Spek A, et al. Single-fraction image-guided robotic radiosurgery efficiently controls local prostate cancer recurrence after radical prostatectomy. BJUI Compass. 2020; doi:10.1002/bco2.32.
  29. Turk H, et al. Predictive factors for biochemical recurrence in radical prostatectomy patients. Central European Journal of Urology. 2015; doi:10.5173/ceju.2015.606.
  30. Tugcu V, et al. Robot-assisted radical perineal prostatectomy: First experience of 15 cases. Turkish Journal of Urology. 2017; doi:10.5152/tud.2017.35488.
  31. Sharma NL, et al. Robotic-assisted laparoscopic prostatectomy. British Journal of Cancer. 2009; doi:10.1038/sj.bjc.6605341.
  32. Linder BJ, et al. Effect of surgical care team consistency during urologic procedures on surgical efficiency and perioperative outcomes. Urology. 2023; doi:10.1016/j.urology.2023.02.004.
  33. Steinberg, RL, et al. Magnet-assisted robotic prostatectomy using the da Vinci SP robot: An initial case series. Journal of Endourology. 2019; doi:10.1089/end.2019.0263.

机器人前列腺切除术